• Biotech startup RWDC raises $22 M in A3 round biospectrumasia
    April 25, 2019
    Funds raised in this round will primarily be used to accelerate the Company's plan to significantly increase PHA production capacity in Georgia, USA, as well as to support its R&D efforts into prioritised applications
PharmaSources Customer Service